TrialRetina (Philadelphia, Pa.)2019

RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION: BRILLIANCE, a 12-Month, Randomized, Double-Masked Study.

Youxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.